Abstract:Background To explore the outcomes and prognostic factors of ovarian metastasectomy intervention on overall survival from extragenital primary cancer. Methods Patients with ovarian metastases from extragenital primary cancer confirmed by laparotomy surgery and ovarian metastases resection were retrospectively collected in a single institution during an 8-year period. A total of 147 cases were identified and primary tumor sites were colorectal region (49.0%), gastric (40.8%), breast (8.2%), biliary duct (1.4%) and liver (0.7%). The pathological and clinical features were evaluated. Patients’ outcome with different primary tumor sites and predictive factors for overall survival were also investigated by univariate and multivariate analysis. Results Metachronous ovarian metastasis occurred in 92 (62.6%) and synchronous in 55 (37.4%) patients. Combined metastases occurred in 40 (27.2%). Bilateral metastasis was found in 97 (66%) patients. The median ovarian metastasis tumor size was 9 cm. There were 39 (26.5%) patients with massive ascites ≥ 1000 mL on intraoperative evaluation. With a median follow-up of 48 months, the median OS after ovarian metastasectomy for all patients was 8.2 months (95% CI 7.2-9.3 months). In univariate analyses, there is significant (8.0 months vs. 41.0 months, P = 0.000) difference in OS between patients with gastrointestinal cancer origin from breast origin, and between patients with gastric origin from colorectal origin (7.4 months vs. 8.8 months, P = 0.036). In univariate analyses, synchronous metastases, locally invasion, massive intraoperative ascites (≥ 1000 mL), and combined metastasis, were identified as significant poor prognostic factors. In multivariate analyses combined metastasis (RR, 1.72; 95% CI, 1.09-2.69, P = 0.018), locally invasion (RR, 1.62; 95% CI, 1.03-2.54, P = 0.038) and massive intraoperative ascites (RR, 1.58; 95% CI, 1.02-2.49, P = 0.04) were independent factors for predicting unfavorable overall survival. Conclusion Ovarian metastases are more commonly originated from primary gastrointestinal tract. The prognosis of ovarian metastasis is dismal and the benefit of ovarian metastatectomy is limited. Combined metastasis outside ovaries, locally invasion and massive intraoperative ascites were independent factors for predicting unfavorable overall survival. The identification of the primary tumor is required to plan for adequate treatment for this group of patients.

Study of Biology Character of Ovarian Metastasis in Gastric Cancer

[Expression and Clinical Significance of CD44v6 and Scd44v6 in Gastric Carcinoma].

[Expression of Sex Hormone Receptor in Gastric Cancer with Synchronous Ovarian Metastasis and Its Significance].

Prognostic Role of Estrogen Receptor Α and Estrogen Receptor Β in Gastric Cancer

Gastric Cancer with Breast Metastasis: Clinical Features and Prognostic Factors

Expression and clinical significance of P16, P15,and VEGF proteins in primary epithelial ovarian carcinoma

Extra-Abdominal Metastases from Epithelial Ovarian Carcinoma an Analysis of 20 Cases

Clinical Significance Of Ngal And Mmp-9 Protein Expression In Epithelial Ovarian Cancers

Comparison of vascular endothelial growth factor C expression between primary and metastatic sites of ovarian cancer

The Clinical Significance of the CD44v6 Expression in Peripheral Blood Mononuclear Cell and Cancerous Tissue of Patients with Gastric Cancer

Expression of CD44V6,VEGF and nm23-H1 on Ovarian Cancerous Tissue and Its Clinical Significance

[Analysis of the Risk Factors for Ovarian Metastasis in Patients with Endometrial Carcinoma].

Expression of cytokeratin 7 and 20 in ovarian metastatic carcinomas

Expression of estrogen receptor and estrogen receptor messenger RNA in gastric carcinoma

Oncogene Expression in Tumor Tissue from Patients with Carcinoma of Endometrium and Its Clinical Significance

Correlation of Molecular Tumor Markers CA125, HE4, and CEA with the Development and Progression of Epithelial Ovarian Cancer

Epression and function of metastases anti-oncogene in ovarian cancer tissue

The Potential Prognostic Value of Expression of Stem Cell Marker of CD44s, EpCAM, and OVA66 in Patients with Gastric Adenocarcinoma.

The Expression of CD44v5+ Cells in Different Tissue of Patients with Gastric Carcinoma

Ovarian metastases resection from extragenital primary sites: outcome and prognostic factor analysis of 147 patients

Study of molecular markers in patients with endometrial carcinoma and its prognosis on the effectiveness